Device surgery without interruption of anticoagulation [3]

New England Journal of Medicine

Volumn 369, Issue 16, 2013, Pages 1571-

  Golwala, Harsh ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT; HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; DEVICE THERAPY; DISEASE PREDISPOSITION; DRUG EXCRETION; DRUG MONITORING; DRUG SAFETY; GLOMERULUS FILTRATION RATE; HEMATOMA; HUMAN; LETTER; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RISK FACTOR; TREATMENT DURATION; ARTIFICIAL HEART PACEMAKER; FEMALE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; NOTE;

ANTICOAGULANTS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEMATOMA; HEPARIN; HUMANS; MALE; PACEMAKER, ARTIFICIAL; WARFARIN;

EID: 84885806772     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1310241     Document Type: Letter

References (9)

1. DH Birnie JS Healey GA Wells Pacemaker or defibrillator surgery without interruption of anticoagulation N Engl J Med 368 2013 2084 2093
2. JD Douketis AC Spyropoulos FA Spencer Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e326S e350S
3. L Skeith J Taylor A Lazo-Langner MJ Kovacs Conservative perioperative anticoagulation management in patients with chronic venous thromboembolic disease: a cohort study J Thromb Haemost 10 2012 2298 2304
4. D Siegal J Yudin S Kaatz JD Douketis W Lim AC Spyropoulos Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates Circulation 126 2012 1630 1639
5. MJ Kovacs C Kearon M Rodger Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin Circulation 110 2004 1658 1663
6. P Korantzopoulos KP Letsas T Liu N Fragakis M Efremidis JA Goudevenos Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices Europace 13 2011 1669 1680
7. JD Douketis PB Berger AS Dunn The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 Suppl 2008 299S 339S
8. JS Healey J Eikelboom J Douketis Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial Circulation 126 2012 343 348
9. MR Patel AS Hellkamp Y Lokhnygina Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) J Am Coll Cardiol 61 2013 651 658